CCL2 and metabolic syndrome: Expression of osteopontin, MCP-1, and COX-2 genes in the liver was increased for the MetS group compared with the CONT group, and these increases were blocked by the low dose of HK L-137, with those in the expression of osteopontin and MCP-1 genes also being inhibited by the high dose (Fig. 11A–C).